Ye Bo, Wang Ming
Department of Thoracic Surgery, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Department of Thoracic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang, China.
Comb Chem High Throughput Screen. 2019;22(3):187-193. doi: 10.2174/1386207322666190415103030.
Patients undergoing surgery for non-small cell lung cancer (NSCLC) are often elderly and have co-morbidity conditions and decreased performance status. Compared with open thoracotomy, video-assisted thoracoscopic lobectomy is associated with fewer postoperative complications. Despite encouraging results for patients with NSCLC who underwent VATS, the procedure is still not widely accepted, and large retrospective studies have yielded conflicting results.
In video-assisted lobectomy for NSCLC, it has remained controversial whether mediastinal lymphadenectomy can be performed as effectively as an open procedure via thoracotomy. To deal with inherent biases in any non-randomized comparison, we analyzed propensity-matched studies and randomized controlled trials. The aim of this study was to evaluate the treatment outcomes of VATS and open thoracotomy for NSCLC patients.
We collected publications on comparison of VATS versus open thoracotomy for NSCLC patients from 2007 to 2017. All trials analyzed the summary Hazard Ratios (HRs) of the endpoints of interest, including perioperative mortality and morbidity, and individual postoperative complications. Revman 5.3 software was used to analyze the combined pooled HRs using fixed- or random-effects models according to heterogeneity.
A systematic literature search was conducted including 15 studies. The results indicated that VATS was associated with lower postoperative morbidity and mortality, and significantly lower rates of prolonged pneumonia, atrial arrhythmias and renal failure.
Compared with lobectomy by thoracotomy, thoracoscopic lobectomy is associated with a lower incidence of major complications, including lower rates of prolonged pneumonia, atrial arrhythmias and renal failure. Lobectomy via VATs may be the preferred strategy for appropriately selected NSCLC patients. The determinants of this advantage should be analyzed to improve the safety and outcomes of other thoracic procedures.
接受非小细胞肺癌(NSCLC)手术的患者通常为老年人,合并多种疾病,身体机能下降。与开胸手术相比,电视辅助胸腔镜肺叶切除术的术后并发症较少。尽管电视辅助胸腔镜手术(VATS)治疗NSCLC患者取得了令人鼓舞的结果,但该手术仍未被广泛接受,大型回顾性研究结果也相互矛盾。
在NSCLC的电视辅助肺叶切除术中,纵隔淋巴结清扫术是否能像开胸手术一样有效仍存在争议。为处理任何非随机对照研究中固有的偏差,我们分析了倾向匹配研究和随机对照试验。本研究的目的是评估VATS和开胸手术治疗NSCLC患者的疗效。
我们收集了2007年至2017年比较VATS与开胸手术治疗NSCLC患者的文献。所有试验分析了感兴趣的终点指标的汇总风险比(HRs),包括围手术期死亡率和发病率,以及个体术后并发症。使用Revman 5.3软件根据异质性采用固定效应或随机效应模型分析合并的汇总HRs。
进行了系统的文献检索,共纳入15项研究。结果表明,VATS术后发病率和死亡率较低,长期肺炎、房性心律失常和肾衰竭的发生率显著降低。
与开胸肺叶切除术相比,胸腔镜肺叶切除术的主要并发症发生率较低,包括长期肺炎、房性心律失常和肾衰竭的发生率较低。对于适当选择的NSCLC患者,VATS肺叶切除术可能是首选策略。应分析这种优势的决定因素,以提高其他胸部手术的安全性和疗效。